Schedule of Investments | |||||||
PRIMECAP Odyssey Aggressive Growth Fund | |||||||
January 31, 2021 (Unaudited) | |||||||
Shares | Value | ||||||
COMMON STOCKS - 95.4% | |||||||
Communication Services - 6.9% | |||||||
51,475 | Alphabet, Inc. - Class A (a) | $ | 94,063,356 | ||||
52,512 | Alphabet, Inc. - Class C (a) | 96,398,379 | |||||
252,000 | ANGI Homeservices, Inc. - Class A (a) | 3,522,960 | |||||
1,104,300 | Baidu, Inc. - ADR (a) | 259,532,586 | |||||
3,766,542 | comScore, Inc. (a) (b) | 12,015,269 | |||||
126,800 | Electronic Arts, Inc. | 18,157,760 | |||||
96,900 | Facebook, Inc. - Class A (a) | 25,032,177 | |||||
1,029,400 | IMAX Corp. (a) | 19,455,660 | |||||
621,983 | Lions Gate Entertainment Corp. - Class B (a) | 7,687,710 | |||||
150,305 | Live Nation Entertainment, Inc. (a) | 9,987,767 | |||||
207,375 | Madison Square Garden Entertainment Corp. - Class A (a) | 18,404,531 | |||||
2,950 | Madison Square Garden Sports Corp. - Class A (a) | 477,575 | |||||
5,500 | Netflix, Inc. (a) | 2,928,145 | |||||
1,217,050 | Pinterest, Inc. - Class A (a) | 83,380,096 | |||||
363,300 | Skillz, Inc. - Class A (a) | 10,034,346 | |||||
231,100 | Snap, Inc. - Class A (a) | 12,234,434 | |||||
5,100 | Take-Two Interactive Software, Inc. (a) | 1,022,295 | |||||
832,158 | T-Mobile US, Inc. (a) | 104,918,481 | |||||
198,500 | Tribune Publishing Co. | 2,900,085 | |||||
7,801,692 | WildBrain Ltd. - CAD (a) | 14,703,482 | |||||
83,589 | ZoomInfo Technologies, Inc. - Class A (a) | 4,013,108 | |||||
800,870,202 | |||||||
Consumer Discretionary - 14.9% | |||||||
727,400 | Alibaba Group Holding Ltd. - ADR (a) | 184,635,942 | |||||
17,590 | Amazon.com, Inc. (a) | 56,397,058 | |||||
31,000 | At Home Group, Inc. (a) | 755,470 | |||||
75,000 | Boot Barn Holdings, Inc. (a) | 4,293,000 | |||||
60,400 | Burlington Stores, Inc. (a) | 15,033,560 | |||||
1,202,300 | CarMax, Inc. (a) | 141,606,894 | |||||
2,041,800 | Chegg, Inc. (a) | 194,501,868 | |||||
13,500 | Darden Restaurants, Inc. | 1,578,015 | |||||
314,000 | eBay, Inc. | 17,744,140 | |||||
2,844,601 | Entain PLC - GBP (a) | 48,368,156 | |||||
9,800 | Five Below, Inc. (a) | 1,722,154 | |||||
722,100 | GAN Ltd. (a) | 17,048,781 | |||||
108,340 | Gildan Activewear, Inc. | 2,699,833 | |||||
1,247,450 | iRobot Corp. (a) | 149,818,745 | |||||
300,000 | Magnite, Inc. (a) | 10,392,000 | |||||
1,073,030 | Norwegian Cruise Line Holdings Ltd. (a) | 24,304,129 | |||||
195,000 | OneSpaWorld Holdings Ltd. (a) | 1,850,550 | |||||
61,200 | Restaurant Brands International, Inc. | 3,531,240 | |||||
1,107,676 | Royal Caribbean Cruises Ltd. | 71,998,940 | |||||
3,824,411 | Sony Corp. - ADR | 366,034,377 | |||||
453,250 | Tesla, Inc. (a) | 359,667,472 | |||||
983,300 | Tuesday Morning Corp. (a) | 2,261,590 | |||||
31,300 | Ulta Beauty, Inc. (a) | 8,756,488 | |||||
824,600 | XPeng, Inc. - ADR (a) | 39,729,228 | |||||
1,724,729,630 | |||||||
Consumer Staples - 0.2% | |||||||
4,200 | Beyond Meat, Inc. (a) | 747,936 | |||||
165,800 | Calavo Growers, Inc. | 12,625,670 | |||||
43,500 | Sanderson Farms, Inc. | 5,924,265 | |||||
19,297,871 | |||||||
Energy - 0.4% | |||||||
604,350 | Cabot Oil & Gas Corp. | 11,077,735 | |||||
175,600 | EOG Resources, Inc. | 8,948,576 | |||||
28,500 | New Fortress Energy, Inc. | 1,273,380 | |||||
8,973,882 | Transocean Ltd. (a) | 30,152,244 | |||||
51,451,935 | |||||||
Financials - 4.5% | |||||||
6,800 | Cboe Global Markets, Inc. | 623,764 | |||||
149,300 | Charles Schwab Corp. (The) | 7,694,922 | |||||
142,271 | CME Group, Inc. - Class A | 25,856,331 | |||||
449,703 | Discover Financial Services | 37,568,189 | |||||
76,000 | LPL Financial Holdings, Inc. | 8,233,840 | |||||
359,820 | MarketAxess Holdings, Inc. | 194,576,263 | |||||
1,795,754 | Morgan Stanley | 120,405,306 | |||||
3,805,138 | NMI Holdings, Inc. - Class A (a) | 80,706,977 | |||||
150,300 | Progressive Corp. (The) | 13,104,657 | |||||
449,300 | Tradeweb Markets, Inc. - Class A | 27,312,947 | |||||
516,083,196 | |||||||
Health Care - 31.3% | |||||||
6,000 | 10x Genomics, Inc. - Class A (a) | 1,026,900 | |||||
396,400 | Abbott Laboratories | 48,991,076 | |||||
973,173 | ABIOMED, Inc. (a) | 338,907,497 | |||||
1,244,900 | Accuray, Inc. (a) | 6,149,806 | |||||
88,200 | Adaptive Biotechnologies Corp. (a) | 4,892,454 | |||||
1,999,300 | Alkermes PLC (a) | 41,965,307 | |||||
1,233,800 | Allogene Therapeutics, Inc. (a) | 42,812,860 | |||||
2,130,000 | Amicus Therapeutics, Inc. (a) | 40,278,300 | |||||
500,000 | Arbutus Biopharma Corp. (a) | 1,890,000 | |||||
296,000 | Arena Pharmaceuticals, Inc. (a) | 21,975,040 | |||||
669,647 | BeiGene Ltd. - ADR (a) | 214,287,040 | |||||
1,476,800 | BeiGene Ltd. - HKD (a) | 36,209,290 | |||||
891,409 | Biogen, Inc. (a) | 251,921,098 | |||||
2,032,090 | BioMarin Pharmaceutical, Inc. (a) | 168,216,410 | |||||
1,868,492 | BioNTech SE - ADR (a) | 218,501,455 | |||||
409,260 | Boston Scientific Corp. (a) | 14,504,174 | |||||
7,047,900 | Calithera Biosciences, Inc. (a) (b) | 20,227,473 | |||||
10,227,700 | Cerus Corp. (a) (b) | 67,400,543 | |||||
17,000 | Charles River Laboratories International, Inc. (a) | 4,403,850 | |||||
108,000 | Edwards Lifesciences Corp. (a) | 8,918,640 | |||||
755,892 | Elanco Animal Health, Inc. (a) | 21,943,545 | |||||
1,204,294 | Eli Lilly & Co. | 250,457,023 | |||||
9,757,107 | Epizyme, Inc. (a) (b) | 106,840,322 | |||||
550,600 | Exact Sciences Corp. (a) | 75,520,296 | |||||
3,374,631 | FibroGen, Inc. (a) | 162,589,722 | |||||
4,248,032 | Fluidigm Corp. (a) (b) | 27,527,247 | |||||
337,800 | Glaukos Corp. (a) | 29,959,482 | |||||
65,363 | Guardant Health, Inc. (a) | 10,163,947 | |||||
157,371 | Health Catalyst, Inc. (a) | 7,818,191 | |||||
13,000 | Illumina, Inc. (a) | 5,543,720 | |||||
275,500 | ImmunoGen, Inc. (a) | 1,964,315 |
758,756 | Insulet Corp. (a) | 202,724,428 | |||||
893,900 | LivaNova PLC (a) | 56,226,310 | |||||
385,100 | Mereo Biopharma Group PLC - ADR (a) | 1,047,472 | |||||
11,158,430 | Nektar Therapeutics (a) (b) | 219,821,071 | |||||
370,500 | NuVasive, Inc. (a) | 19,910,670 | |||||
823,400 | OraSure Technologies, Inc. (a) | 12,540,382 | |||||
19,500 | Penumbra, Inc. (a) | 5,091,255 | |||||
438,692 | Pulmonx Corp. (a) | 24,882,610 | |||||
227,000 | QIAGEN N.V. - EUR (a) | 12,305,486 | |||||
3,777,480 | Rhythm Pharmaceuticals, Inc. (a) (b) | 115,930,861 | |||||
177,600 | Roche Holding AG - CHF | 61,240,348 | |||||
1,754,573 | Seagen, Inc. (a) | 288,223,707 | |||||
15,400 | Seer, Inc. (a) | 960,960 | |||||
276,500 | Shockwave Medical, Inc. (a) | 32,085,060 | |||||
39,625 | Sio Gene Therapies, Inc. (a) | 100,251 | |||||
397,540 | Turning Point Therapeutics, Inc. (a) | 49,887,295 | |||||
3,252,220 | Wave Life Sciences Ltd. (a) (b) | 33,075,077 | |||||
4,273,241 | Xencor, Inc. (a) (b) | 195,500,776 | |||||
921,930 | Zentalis Pharmaceuticals, Inc. (a) | 35,374,454 | |||||
3,620,735,496 | |||||||
Industrials - 9.1% | |||||||
2,906,600 | AECOM (a) | 145,620,660 | |||||
604,800 | Alaska Air Group, Inc. | 29,532,384 | |||||
5,553,100 | American Airlines Group, Inc. | 95,346,727 | |||||
272,000 | Axon Enterprise, Inc. (a) | 44,651,520 | |||||
80,100 | Bloom Energy Corp. - Class A (a) | 2,796,291 | |||||
41,000 | Controladora Vuela Compania de Aviacion, S.A.B. de C.V. - ADR (a) | 462,480 | |||||
340,000 | Cornerstone Building Brands, Inc. (a) | 3,869,200 | |||||
417,300 | Curtiss-Wright Corp. | 43,311,567 | |||||
3,135,297 | Delta Air Lines, Inc. | 119,015,874 | |||||
1,509,078 | Everarc Holdings Ltd. (a) | 21,127,092 | |||||
17,500 | FedEx Corp. | 4,118,450 | |||||
320,300 | Gibraltar Industries, Inc. (a) | 28,708,489 | |||||
326,100 | Hawaiian Holdings, Inc. | 6,381,777 | |||||
1,205,700 | Jacobs Engineering Group, Inc. | 121,727,472 | |||||
6,378,225 | JetBlue Airways Corp. (a) | 91,463,747 | |||||
380,300 | Lyft, Inc. - Class A (a) | 16,908,138 | |||||
133,500 | Masonite International Corp. (a) | 13,283,250 | |||||
3,632,600 | NN, Inc. (a) (b) | 21,904,578 | |||||
37,500 | Old Dominion Freight Line, Inc. | 7,275,000 | |||||
15,800 | Ryanair Holdings PLC - ADR (a) | 1,502,106 | |||||
1,882,000 | Southwest Airlines Co. | 82,695,080 | |||||
301,300 | Spirit Airlines, Inc. (a) | 7,815,722 | |||||
39,500 | TransDigm Group, Inc. (a) | 21,854,560 | |||||
266,700 | Uber Technologies, Inc. (a) | 13,583,031 | |||||
2,523,070 | United Airlines Holdings, Inc. (a) | 100,897,569 | |||||
279,200 | WillScot Mobile Mini Holdings Corp. (a) | 6,619,832 | |||||
1,052,472,596 | |||||||
Information Technology - 27.8% | |||||||
169,700 | 2U, Inc. (a) | 6,940,730 | |||||
62,200 | 908 Devices, Inc. (a) | 3,427,842 | |||||
237,100 | Adobe, Inc. (a) | 108,774,367 | |||||
277,500 | Ambarella, Inc. (a) | 26,184,900 | |||||
119,300 | Applied Materials, Inc. | 11,533,924 | |||||
2,694,300 | Arlo Technologies, Inc. (a) | 22,659,063 | |||||
68,400 | ASML Holding N.V. - ADR | 36,536,544 |
31,700 | Autodesk, Inc. (a) | 8,794,531 | |||||
2,205,000 | Axcelis Technologies, Inc. (a) (b) | 75,499,200 | |||||
13,532,126 | BlackBerry Ltd. (a) | 190,802,977 | |||||
201,100 | Cerence, Inc. (a) | 22,505,101 | |||||
175,000 | Corning, Inc. | 6,277,250 | |||||
841,900 | Cree, Inc. (a) | 85,099,252 | |||||
164,099 | CrowdStrike Holdings, Inc. - Class A (a) | 35,412,564 | |||||
89,000 | CyberArk Software Ltd. (a) | 14,262,250 | |||||
100,000 | Dell Technologies, Inc. - Class C (a) | 7,289,000 | |||||
1,163,200 | Descartes Systems Group, Inc. (The) (a) | 71,024,992 | |||||
282,100 | Digimarc Corp. (a) | 10,962,406 | |||||
28,825 | DocuSign, Inc. (a) | 6,713,054 | |||||
75,400 | FARO Technologies, Inc. (a) | 5,320,978 | |||||
9,816,100 | Flex Ltd. (a) | 173,156,004 | |||||
1,016,100 | FormFactor, Inc. (a) | 41,528,007 | |||||
1,285,860 | Hewlett Packard Enterprise Co. | 15,867,512 | |||||
510,000 | HP, Inc. | 12,413,400 | |||||
278,892 | HubSpot, Inc. (a) | 103,803,602 | |||||
148,650 | Intuit, Inc. | 53,696,840 | |||||
763,000 | Jabil, Inc. | 31,565,310 | |||||
179,800 | Keysight Technologies, Inc. (a) | 25,457,882 | |||||
126,188 | Keywords Studios PLC - GBP (a) | 4,716,597 | |||||
506,100 | KLA Corp. | 141,743,427 | |||||
143,600 | MACOM Technology Solutions Holdings, Inc. (a) | 8,165,096 | |||||
481,624 | Materialise NV - ADR (a) | 31,445,231 | |||||
2,641,500 | MaxLinear, Inc. (a) | 82,916,685 | |||||
5,040,200 | Micron Technology, Inc. (a) | 394,496,454 | |||||
34,900 | MongoDB, Inc. (a) | 12,899,389 | |||||
400 | nCino, Inc. (a) | 28,680 | |||||
1,985,567 | NetApp, Inc. | 131,921,072 | |||||
1,101,703 | nLIGHT, Inc. (a) | 34,901,951 | |||||
1,264,000 | Nuance Communications, Inc. (a) | 57,562,560 | |||||
1,870,925 | Nutanix, Inc. - Class A (a) | 57,100,631 | |||||
162,560 | NVIDIA Corp. | 84,464,550 | |||||
3,300 | Okta, Inc. - Class A (a) | 854,733 | |||||
245,000 | OSI Systems, Inc. (a) | 22,054,900 | |||||
33,200 | Palo Alto Networks, Inc. (a) | 11,644,900 | |||||
20,616 | Perspecta, Inc. | 596,833 | |||||
1,528,000 | Plantronics, Inc. | 48,468,160 | |||||
189,400 | Pluralsight, Inc. - Class A (a) | 3,939,520 | |||||
1,370,893 | PROS Holdings, Inc. (a) | 57,769,431 | |||||
690,623 | QUALCOMM, Inc. | 107,930,563 | |||||
196,600 | Rapid7, Inc. (a) | 17,068,812 | |||||
21,650 | RingCentral, Inc. - Class A (a) | 8,073,718 | |||||
6,820,500 | ServiceSource International, Inc. (a) (b) | 10,708,185 | |||||
1,523,500 | Splunk, Inc. (a) | 251,423,205 | |||||
1,991,300 | Stratasys Ltd. (a) | 82,658,863 | |||||
815,000 | Trimble, Inc. (a) | 53,716,650 | |||||
136,200 | Unity Software, Inc. (a) | 20,405,484 | |||||
887,329 | Universal Display Corp. | 204,813,280 | |||||
225,000 | VMware, Inc. - Class A (a) | 31,016,250 | |||||
358,830 | Western Digital Corp. | 20,248,777 | |||||
600 | Zoom Video Communications, Inc. - Class A (a) | 223,242 | |||||
3,209,487,311 | |||||||
Materials - 0.2% | |||||||
110,200 | Albemarle Corp. | 17,925,132 | |||||
26,000 | Ingevity Corp. (a) | 1,707,940 | |||||
1,737,400 | Marrone Bio Innovations, Inc. (a) | 2,884,084 | |||||
22,517,156 | |||||||
Real Estate - 0.1% | |||||||
237,089 | EPR Properties | 9,398,208 | |||||
10,000 | Safehold, Inc. | 735,800 | |||||
10,134,008 | |||||||
TOTAL COMMON STOCKS | |||||||
(Cost $4,937,834,273) | $ | 11,027,779,401 | |||||
PREFERRED STOCKS - 0.1% | |||||||
Financials - 0.1% | |||||||
779,276 | Fannie Mae Fixed-to-Floating Rate Non-Cumulative Preferred Stock Series S, Perpetual Maturity 7.750% (a) | 4,480,837 | |||||
1,512,400 | Freddie Mac Fixed-to-Floating Rate Non-Cumulative Preferred Stock Series Z, Perpetual Maturity 7.875% (a) | 8,348,448 | |||||
12,829,285 | |||||||
TOTAL PREFERRED STOCKS | |||||||
(Cost $12,785,458) | 12,829,285 | ||||||
RIGHTS - 0.0% | |||||||
Health Care - 0.0% | |||||||
2,980,900 | Ligand Pharmaceuticals, Inc. - CVR (Issue Date 10/1/20) (a) (c) (d) | 2,235,675 | |||||
3,786,300 | Mereo BioPharma Group PLC - CVR (Issue Date 4/23/19) (a) (c) (d) | 0 | |||||
2,235,675 | |||||||
Consumer Discretionary - 0.0% | |||||||
983,300 | Tuesday Morning Corp. (Issue Date 1/5/21) (a) (c) (d) | 1,179,960 | |||||
TOTAL RIGHTS | |||||||
(Cost $0) | 3,415,635 | ||||||
WARRANTS - 0.0% | |||||||
Industrials - 0.0% | |||||||
364,100 | Everarc Holdings Ltd. (Expiration Date 12/1/22) (a) (c) | 109,230 | |||||
TOTAL WARRANTS | |||||||
(Cost $3,641) | 109,230 | ||||||
Shares | Value | ||||||
SHORT-TERM INVESTMENTS - 4.5% | |||||||
518,917,073 | Dreyfus Treasury Securities Cash Management Fund - Institutional Shares - 0.01% (e) | $ | 518,917,073 | ||||
TOTAL SHORT-TERM INVESTMENTS | |||||||
(Cost $518,917,073) | 518,917,073 | ||||||
TOTAL INVESTMENTS IN SECURITIES | |||||||
(Cost $5,469,540,445) - 100.0% | 11,563,050,624 | ||||||
Liabilities in Excess of Other Assets - (0.0)% | (917,328 | ) | |||||
TOTAL NET ASSETS - 100.0% | $ | 11,562,133,296 |
ADR | American Depository Receipt | ||||
CAD | Canadian Dollars | ||||
CHF | Swiss Francs | ||||
CVR | Contingent Value Rights | ||||
EUR | Euros | ||||
GBP | British Pound Sterling | ||||
HKD | Hong Kong Dollars | ||||
(a) | Non-Income Producing | ||||
(b) | Considered an affiliated company of the fund as the fund owns 5% or more of the outstanding voting securities of such company. | ||||
(c) | Illiquid security | ||||
(d) | Fair-valued security | ||||
(e) | Rate quoted is seven-day yield at period end. | ||||
The Global Industry Classification Standard (GICS ®) was developed by and is the exclusive property of MSCI Inc. and Standard & Poor’s Financial Services LLC (“S&P”). GICS is a service mark of MSCI and S&P and has been licensed for use by the fund’s administrator. |
Security Valuation
Securities traded on a national securities exchange are valued at the last reported sales price at the close of regular trading on each day the exchanges are open for trading. Securities traded on the National Association of Securities Dealers Automated Quotations (“NASDAQ”) are valued at the NASDAQ Official Closing Price, which may not necessarily represent the last sale price. Non-U.S. traded stocks are valued at the last sale price or official closing price in the primary local market where the stock is traded. Securities traded on an exchange for which there have been no sales are valued at the mean between the bid and ask price. Because trading on most non-U.S. exchanges is normally completed before the close of the New York Stock Exchange, the value of securities traded on foreign exchanges can change by the time the Fund calculates its net asset value per share (“NAV”). To address these changes, the Fund may utilize adjustment factors provided by an independent pricing service to systematically value foreign securities at fair value. These adjustment factors are based on statistical analyses of subsequent movement in securities indices, specific security prices, and exchange rates in foreign markets.
Securities for which quotations are not readily available are valued at their respective fair values as determined in good faith by a valuation committee of the Investment Advisor in accordance with procedures approved by the Trust’s Board of Trustees. In determining fair value, the Fund takes into account all relevant factors and available information. Consequently, the price of a security used by the Fund to calculate its NAV may differ from quoted or published prices for the same security. Fair value pricing involves subjective judgments, and there is no single standard for determining a security’s fair value. As a result, different mutual funds could reasonably arrive at a different fair value for the same security. It is possible that the fair value determined for a security is materially different from the value that could be realized upon the sale of that security or from the values that other mutual funds may determine.
Investments in other funds are valued at their respective new asset values as determined by those funds, in accordance with the 1940 Act.
Valuation Measurements
The Fund has adopted fair valuation accounting standards which establish an authoritative definition of fair value and set forth a hierarchy for measuring fair value. These standards require additional disclosure about the various inputs and valuation techniques used to develop the measurements of fair value and a discussion of changes in valuation techniques and related inputs during the period. These standards define fair value as the price that would be received in the sale of an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy is organized into three levels based upon the assumptions (referred to as “inputs”) used to value the asset or liability. These standards state that “observable inputs” reflect the assumptions that market participants would use in valuing an asset or liability based on market data obtained from independent sources. “Unobservable inputs” reflect the Fund’s own assumptions about the inputs market participants would use to value the asset or liability.
Various inputs are used in determining the value of the Fund’s investments, and at the lowest level for any significant input determines leveling. These inputs are summarized in the three broad levels below:
Level 1 – | Unadjusted quoted prices in active markets for identical securities to which the Trust has access at the date of measurement. |
Level 2 – | Other significant observable inputs (including quoted prices for similar or related securities in both active and inactive markets, interest rates, foreign exchange rates, and fair value estimates for foreign securities indices). |
Level 3 – | Significant unobservable inputs to the extent observable inputs are unavailable (including the Fund’s own assumptions in determining fair value of investments based on the best available information). |
The following table provides the fair value measurements of the Fund assets by level within the fair value hierarchy for the Fund as of January 31, 2021. These assets are measured on a recurring basis.
Quoted prices | Significant | ||||||||||||||||
in active | other | Significant | |||||||||||||||
markets for | observable | unobservable | |||||||||||||||
identical assets | inputs | inputs | |||||||||||||||
Fund | Description | (Level 1) | (Level 2) | (Level 3) | Total | ||||||||||||
Aggressive | Common Stocks(1) | $ | 11,027,779,401 | $ | - | $ | - | $ | 11,027,779,401 | ||||||||
Growth Fund | Preferred Stocks(2) | 12,829,285 | - | - | 12,829,285 | ||||||||||||
Rights(3) | - | - | 3,415,635 | 3,415,635 | |||||||||||||
Warrants(4) | 109,230 | - | - | 109,230 | |||||||||||||
Short-Term Investments | 518,917,073 | - | - | 518,917,073 | |||||||||||||
Total Investments in Securities | $ | 11,559,634,989 | $ | - | $ | 3,415,635 | $ | 11,563,050,624 | |||||||||
(1) Refer to the Fund’s respective Schedule of Investments for the breakdown of major categories. | |||||||||||||||||
(2) Financials | |||||||||||||||||
(3) Health Care & Consumer Discretionary | |||||||||||||||||
(4) Industrials | |||||||||||||||||
Following is a reconciliation of investments in which significant unobservable inputs (Level 3) were used in determining fair value. | |||||||||||||||||
Aggressive Growth Fund | Ligand Pharmaceuticals, Inc. - CVR | Tuesday Morning Corp. | |||||||||||||||
Balance at October 31, 2020 | $ | 2,235,675 | $ | - | |||||||||||||
Purchase (Received) | - | 1,179,960 | |||||||||||||||
Sales | - | - | |||||||||||||||
Realized Gain (Loss) | - | - | |||||||||||||||
Change in unrealized appreciation | - | - | |||||||||||||||
Transfer into Level 3 | - | - | |||||||||||||||
Balance at January 31, 2021 | $ | 2,235,675 | $ | 1,179,960 |
Other Affiliates | ||||||||||||||||||||||||||||
Certain of the Funds’ investments are in companies that are considered to be affiliated companies of a Fund because the Fund owns 5% or more of the outstanding voting securities of the company. With respect to each such investment, refer to each Fund’s respective Schedule of Investments for the information on the sector, the number of shares held, and the percentages of net assets held in each sector. Transactions during the period in securities of these companies were as follows: | ||||||||||||||||||||||||||||
PRIMECAP Odyssey Aggressive Growth Fund | ||||||||||||||||||||||||||||
Current Period Transactions | ||||||||||||||||||||||||||||
Common Stock | Market Value at October 31, 2020 | Purchases at Cost | Proceeds from Securities Sold | Dividend Income | Realized Gain (Loss) | Change in Unrealized Gain (Loss) | Market Value at January 31, 2021 | |||||||||||||||||||||
Axcelis Technologies, Inc. | $ | 52,175,687 | $ | - | $ | 5,086,440 | $ | - | $ | 3,613,929 | $ | 24,796,024 | $ | 75,499,200 | ||||||||||||||
Calithera Biosciences, Inc. | 24,949,566 | - | - | - | - | (4,722,093 | ) | 20,227,473 | ||||||||||||||||||||
Cerus Corp | 56,543,025 | - | 3,515,547 | - | 532,347 | 13,840,718 | 67,400,543 | |||||||||||||||||||||
comScore, Inc. | 7,514,251 | - | - | - | - | 4,501,018 | 12,015,269 | |||||||||||||||||||||
Epizyme, Inc. | 120,597,842 | - | - | - | - | (13,757,520 | ) | 106,840,322 | ||||||||||||||||||||
Fluidigm Corp. | 25,397,962 | - | 1,087,400 | - | (3,086,933 | ) | 6,303,618 | 27,527,247 | ||||||||||||||||||||
Nektar Therapeutics | 178,046,827 | - | 1,361,418 | - | (334,797 | ) | 43,470,459 | 219,821,071 | ||||||||||||||||||||
NMI Holdings, Inc. - Class A(1) | 91,535,559 | 339,799 | 11,107,572 | - | 2,600,564 | (2,661,373 | ) | N/A | ||||||||||||||||||||
NN, Inc. | 20,575,968 | - | 1,334,868 | - | (3,721,043 | ) | 6,384,521 | 21,904,578 | ||||||||||||||||||||
Rhythm Pharmaceuticals, Inc. | 73,281,649 | 9,537,478 | - | - | - | 33,111,734 | 115,930,861 | |||||||||||||||||||||
ServiceSource International, Inc. | 9,480,495 | - | - | - | - | 1,227,690 | 10,708,185 | |||||||||||||||||||||
Wave Life Sciences Ltd. | 20,185,557 | 3,439,347 | - | - | - | 9,450,173 | 33,075,077 | |||||||||||||||||||||
Xencor, Inc. | 164,006,990 | - | - | - | - | 31,493,786 | 195,500,776 | |||||||||||||||||||||
Total | $ | 844,291,378 | $ | 13,316,624 | $ | 23,493,245 | $ | - | $ | (395,933 | ) | $ | 153,438,755 | $ | 906,450,602 | |||||||||||||
(1) No longer an affiliate as of January 31, 2021. |